Placontx
The startup develops platinum-based cytotoxic oncology drugs that enhance the efficacy and reduce the side effects of conventional platinum therapies. By providing pharmaceutical companies and healthcare professionals with improved treatment options, the company aims to increase the effectiveness of cancer therapies for patients.
Traction –/10
North Attleborough, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops platinum-based cytotoxic oncology drugs that enhance the efficacy and reduce the side effects of conventional platinum therapies. By providing pharmaceutical companies and healthcare professionals with improved treatment options, the company aims to increase the effectiveness of cancer therapies for patients.